Autore
MARIA LETIZIA TRINCAVELLI
Unimap Dati autore
- Ricercatore Universitario presso Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie
- Membro della Facolta' di Farmacia
- Settore scientifico disciplinare BIO/10 BIOCHIMICA
- In servizio
Prodotti
- Abstract
- A2a adenosine receptor gene regulation by cytokines in PC12 cells. 2001
- Serotonine-mediated MAP Kinase activation in patients affected by panic disorder versus control 2001
- A2 adenosine receptors heterologous regulation by proinflammatory cytokines in human astrocytoma cells. 2002
- A2A adenosine receptors and cytokines: modulation of apoptosis in PC 12 cells. 2002
- Modulation of serotonin-mediated intracellular signalling by 3,4-methylendioxymethamphetamine (MDMA) 2002
- A2B adenosine receptors in human astroglial cells: regulation of receptor expression and functioning by tumor necrosis factor alpha 2003
- Cyclic AMP inhibitory pathway in platelet of patients with panic disorder versus control 2003
- Short-term regulation of A2B adenosine receptor functioning by tumor necrosis factor alpha in human astroglial cells 2004
- Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in the brain 2006
- Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in the brain 2006
- Correlation between lymphocytic peripheral benzodiazepine receptor levels and psychiatric scale scorse in post-traumatic stress disorder and traumatic grief 2006
- Correlations between anxiety spectrum assessments and saliva cortisol changes in post-traumatic stress disorder and traumatic grief. 2006
- Peripheral-type benzodiazepine receptor and steroid serum levels in civilian population with post-traumatic stress disorder 2006
- Panic-agoraphobic spectrum comorbidity and mitochondrial translocator protein in post-traumatic stress disorder. 2007
- Cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein levels in PTSD patients versus controls 2008
- GPR17 and vascular endothelial growth factor receptor stimulation in PC12 cells, a model of neuronal differentiation. 2008
- Articoli
- "Isosteric replacement of amide by ester function. Synthesis and benzodiazepine receptor affinity of indol-3-ylglyoxylyl ester derivatives." 1997
- Chemical modifications of striatal A2A adenosine receptors: a possible role for tyrosine at the ligand binding sites. 1997
- Peripheral benzodiazepine receptors in isolated human pancreatic islets 1997
- 1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-Triazolo[1,5-a][1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. 1998
- 1,2,3-Triazolo[1,5-a]quinoxalines: Synthesis and Binding to Benzodiazepine and Adenosine Receptors. 1998
- 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies 1998
- A1 adenosine receptors in human neutrophils. Electron microscope localization 1998
- A1 adenosine receptors in human neutrophils. Electron microscope localization. 1998
- Characterization of Sulphonylurea Receptors in Isolated Human Pancreatic Islets 1998
- Characterization of [3H]glibenclamide binding to human cerebral cortex: modulation by purine nucleotides 1998
- Synthesis and A1 and A2A adenosine binding activity of some pyrano[2,3-c]pyrazol-4-ones 1998
- 4-Amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo [4,3-a]-quinoxalin-1-one: a new A2a adenosine receptor antagonist with high selectivity versus A1 receptors 1999
- A1 Adenosine receptors in human neutrophils: direct binding and electron microscope visualization 1999
- Intracellular Hyperinsulinism: A metabolic characteristic of obesity with and without type 2 diabetes. 1999
- 1,2,4-triazolo[4,3-a] quinoxalin-1-one: a versatile tool for the synthesis of selective adenosine receptor antagonists. 2000
- 3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands. 2000
- A novel class of hyghly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives 2000
- Agonist-Induced Internalization and Recycling of the human A3 Adenosine Receptors: Role in Receptor Desensitization and Resensitization. 2000
- Short and long term desensitization of human A3 adenosine receptors in transfected CHO cells 2000
- Synthesis and structure-activity relathionships of a new set of 2-arylpyrazol [3,4-c] quinoline derivatives as adenosine receptor antagonists 2000
- The direct activation of peripheral benzodiazepine receptors causes functional damage and apoptosis of human pancreatic beta cells 2000
- 3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 2001
- Novel N-(Arylalkyl)indol-3-ylglyoxylylamides Targeted as Ligands of the Benzodiazepine Receptor: Synthesis Biological Evaluation, and Molecular Modeling Analysis of the structure-Activity Relationships 2001
- Synthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands 2001
- The A3 adenosine receptor induces cytoskeleton rearrangement in human 2001
- A(3) adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation. 2002
- Design, Synthesis and Biological Evaluation of Novel N-Alkyl- and N-Acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs) as Novel A(1) Adenosine Receptor Antagonists. 2002
- Involvement of mitogen protein kinase cascade in agonist-mediated human A(3) adenosine receptor regulation. 2002
- New 1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. II. 2002
- Synthesis, molecular modeling studies, and pharmacological activity of selective a(1) receptor antagonists. 2002
- Up-regulation of A(2A) adenosine receptors by proinflammatory cytokines in rat PC12 cells. 2002
- Upregulation of mitochondrial peripheral benzodiazepine receptor expression by cytokine-induced damage of human pancreatic islets. 2002
- A(2A) adenosine receptor ligands and proinflammatory cytokines induce PC 12 cell death through apoptosis. 2003
- Geometrically Constrained Analogues of N-Benzylindolylglyoxylylamides: [1, 2,4]Triazino[4, 3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 2003
- Synthesis and structure-activity relationships of a new set of 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as adenosine receptor antagonists 2003
- Synthesis of 4-amino-6-(hetero)arylalkylamino-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent A(2A) adenosine receptor antagonists. 2003
- 1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists. 2004
- 1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies. 2004
- Adenosine: old passion, new perspectives 2004
- Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor. 2004
- Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells 2004
- Serotonin-mediated cyclic AMP inhibitory pathway in platelets of patients affected by panic disorder 2004
- Serotonin-mediated cyclic AMP inibitory pathway in platelets of patients affected by panic disorder 2004
- Serotonin-mediated phosphorylation of extracellular regulated kinases in platelets of patients with panic disorders versus controls 2004
- Synthesis and structure-activity relationships of 4-cycloalkylamino-1, 2, 4-triazolo[4, 3-a]quinoxalin-1- one derivatives as A1 and A3 adenosine receptor antagonists 2004
- Synthesis of1-(2-chloro-2-phenylethyl)-6-methylthio-1H-pyrazolo[3,4-d]pyrimidines 4-amino substituted and their biological evaluation. 2004
- The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets. 2004
- 1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives. 2005
- 1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. 2005
- 2- and 8-alkynyl-9-ethyladenines: synthesis and biological activity at human and rat adenosine receptors. 2005
- 2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 2005
- 2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1and A3 adenosine receptor antagonists. 2005
- A2B adenosine receptor activity is reduced in neutrophils from patients with systemic sclerosis 2005
- Differences in the neurotoxicity profile induced by ATP and ATPgammaS in cultured cerebellar granule neurons. 2005
- New pyrazolo[3,4-b]pyridones as selective A(1) adenosine receptor antagonists: synthesis, biological evaluation and molecular modelling studies. 2005
- Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors. 2005
- Synthesis and benzodiazepine receptor affinity of derivatives of the new tricyclic heteroaromatic system 2005
- 4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies. 2006
- The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. 2006
- Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics. 2006
- 5-Amino-2-phenyl1,2,3triazolo1,2-a1,2,4benzotriazin-1-one: A Versatile Scaffold To Obtain Potent and Selective A3 Adenosine Receptor Antagonists 2007
- Co-localization and functional cross-talk between A(1) and P2Y(1) purine receptors in rat hippocampus 2007
- GABAA/Bz receptor subtypes as targets for selective drugs. 2007
- New 2-Arylpyrazolo3,4-cquinoline Derivatives as Potent and Selective Human A(3) Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand-Receptor Modeling Studies. 2007
- The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor. 2007
- Derivatives of 4-Amino-6-hydroxy-2-mercaptopyrimidine as Novel, Potent, and Selective A3 Adenosine Receptor Antagonists. 2008
- Norepinephrine-mediated Regulation of 5HT(1) Receptor Functioning in Human Platelets. 2008
- Regulation of A(1) adenosine receptor functioning induced by P2Y(1) purinergic receptor activation in human astroglial cells. 2008
- Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain. 2008
- Short-term TNF-Alpha treatment induced A(2B) adenosine receptor desensitization in human astroglial cells. 2008
- Structure-Based Optimization of Pyrazolo3,4-dpyrimidines as Abl Inhibitors and Antiproliferative Agents toward Human Leukemia Cell Lines. 2008
- Substituted Pyrazolo3,4-bpyridines as Potent A1 Adenosine Antagonists: Synthesis, Biological Evaluation, and Development of an A1 Bovine Receptor Model 2008
- Synthesis and AT1 affinity evaluation of benzamidophenyl analogs of known AT1 receptor ligands with similar aromatic skeleton 2008
- Synthesis and Affinity Evaluation for AT1 Receptor of Phenylsalicylaldoxime-Derivatives Structurally Related to Sartans 2008
- Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo4,3-aquinoxalin-1-one derivatives as potent and selective human A(3) adenosine receptor antagonists. 2008
- The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. 2008
- Adenosine A2A receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease. 2009
- Functional characterization of two isoforms of the P2Y-like receptor GPR17: 35SGTPgammaS binding and electrophysiological studies in 1321N1 cells. 2009
- Pyrido2,3-e-1,2,4-triazolo4,3-apyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies. 2009
- Adenosine receptors: what we know and what we are learning. 2010
- Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 2010
- Lifetime manic-hypomanic symptoms in post-traumatic stress disorder: Relationship with the 18 kDa mitochondrial translocator protein density. 2010
- Novel N2-substituted pyrazolo3,4-dpyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation. 2010
- Receptor cross-talk: haloperidol treatment enhances A2A adenosine receptor functioning in a transfected cell model. 2010
- Regulation of PC12 cell survival and differentiation by the new P2Y-like receptor GPR17. 2010
- A2A adenosine receptor binding parameters in platelets from patients affected by pathological gambling 2011
- Agonist-Induced Desensitization/Resensitization of Human G Protein-Coupled Receptor 17: A Functional Cross-Talk between Purinergic and Cysteinyl-Leukotriene Ligands 2011
- Cyclic adenosine monophosphate responsive element binding protein in post-traumatic stress disorder. 2011
- Derivatives of Benzimidazol-2-ylquinoline and Benzimidazol-2-ylisoquinoline as Selective A(1) Adenosine Receptor Antagonists with Stimulant Activity on Human Colon Motility. 2011
- In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases. 2011
- PHENOTYPIC CHANGES, SIGNALING PATHWAY AND FUNCTIONAL CORRELATES OF GPR17-EXPRESSING NEURAL PRECURSOR CELLS DURING OLIGODENDROCYTE DIFFERENTIATION 2011
- Substituted pyrazolo3,4-bpyridines as human A(1) adenosine antagonists: Developments in understanding the receptor stereoselectivity. 2011
- The Identification of the 2-Phenylphthalazin-1(2H)-one Scaffold as a New Decorable Core Skeleton for the Design of Potent and Selective Human A(3) Adenosine Receptor Antagonists. J Med Chem. 2011
- A new D₂ dopamine receptor agonist allosterically modulates A(2A) adenosine receptor signalling by interacting with the A(2A)/D₂ receptor heteromer. 2012
- Atti, Riassunti o Comunicazioni
- A1 adenosine receptors in human neutrophils: electron microscope localization 1997
- Determinazione dell’attività dell’enzima elastasi nel liquido sinoviale di pazienti affetti da artrite reumatoide 1997
- Effect of FMLP stimulation on [3H] NECA binding to adenosine receptors in human neutrophils membranes 1997
- Functional arginyl residues in A2a adenosine receptors: specific reagent modification by 2,3 butanedione. 1997
- Modulation of A2-like adenosine receptors in neutrophils membranes 1997
- The effect of noise exposure on peripheral benzodiazepine receptors in rat heart 1997
- Thioredoxin reductase (TR) activity in platelets from patients with systemic sclerosis 1997
- )[3H] NECA binding sites on neutrophils in healthy volunteers and patients affected by systemic sclerosis 1998
- Adenosine analogues modulation of chemetoctic peptide receptors trafficking in human neutrophils 1998
- Characterization of [3H] glibenclamide binding to human cerebral cortex: modulation by purine nucleotides 1998
- Distribution of A1 adenosine receptors in human neutrophils: cytochemical analysis using CHAox-biotin-streptavidin-gold complex 1998
- Effect of FMLP stimulation on A2a adenosine and adenotin receptors in human neutrophils 1998
- 1,2,4-triazolo[4,3-a]quinoxalin-1-ones as a framework to obtain potent and selective A1, A2a and A3 adenosine receptor antagonists 1999
- 5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one. a new class of A2a and A3 adenosine receptor antagonists 1999
- Adenosine derivatives fluorescent ligands: visualization of human A3 adenosine receptors in CHO transfected cells. 1999
- Agonist-induced internalization and recycling of human A3 adenosine receptors in transfected CHO cells 1999
- Interaction at the BzR of closed-chain analogues of N-benzyl-indol-3ylglyoxylamide derivatives 1999
- Synthesis and preliminary A1 binding study of new rationally designed 2,5 quinolinediones. 1999
- 3-aryl-[1,2,4]triazino[4,3-a]benzoimidazol-4(10H)-ones: selective A1 adenosine receptor antagonists 2000
- 4,5-dihydro-2-phenytl-1,2,4-triazolo[1,5-a] quinazoline derivatives as highly potent and selective A3 adenosine receptor antagonists 2000
- 6-arylalkylamino-1,2-dihydro-2-phenytl-1,2,4-triazolo[4,3-a] quinoxalin-1-ones as A2a adenosine receptor antagonists. 2000
- Benzosubstituted 2-phenytl-1,2,4-triazolo[4,3-a] quinoxalin-1-ones, symthesis and binding activity on adenosine receptors. 2000
- Cytokines exposure effects on peripheral benzodiazepine receptors in human pancreatic islets 2000
- Derivati Indol-3-ilgliossililammidici a catena chiusa otticamente attivi: possibilità di due diversi modi di legame al recettore centrale delle benzodiazepine 2000
- Effetti diretti della glimepiride su isole pancreatiche umane 2000
- Human A3 adenosine receptors-mediated activation of the mitogen protein kinases: relathionships with receptor internalization and desensitization. 2000
- Indol-3-ylglyoxylilamide derivatives probing the existence of a hydrogen acceptor/donor group in the S1 region of the benzodiazepine receptor binding site 2000
- L’attivazione diretta dei recettori periferici delle benzodiazepine provoca danno funzionale e apoptosi delle beta cellule pancreatiche umane 2000
- Short and long term desensitization of human A3 adenosine receptors in transfected CHO cells. 2000
- Stimulation of mitogen protein kinases by human A3 adenosine receptors: role in receptor desensitization and endocytosis 2000
- Stimulation of mitogen protein kinases by human A3 adenosine receptors: role in receptor desensitization and endocytosis 2000
- A2A adenosine receptor gene regulation by cytokines in PC12 cells 2001
- A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization and down-regulation 2001
- Agonist-mediated regulation of A3 adenosine receptors in human astrocytoma cells 2001
- Attivazione delle map-chinasi mediata dalla serotonina in pazienti affetti da disturbo di panico versus controlli prima e dopo trattamento con paroxetina 2001
- A2 adenosine receptors heterologous regulation by proinflammatory cytokines in human astrocytoma cells. 2002
- A2A adenosine receptors and cytokines: modulation of apoptosis in PC 12 cells. 2002
- A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization and down-regulation. 2002
- Antagonisti adenosinici A1 selettivi: progettazione, sintesi e valutazione biologica. 2002
- Confronto tra le affinità verso i recettori adenosinici umani e bovini di ligandi selettivi 1.8-naftiridinici. 2002
- Funzione del recettore 5-HT1 piastrinico in pazienti con attacchi di panico versus controlli prima e dopo trattamento con paroxetina 2002
- Intracellular trafficking of A3 adenosine receptors in human astrocytoma cells 2002
- Modulation of serotonin-mediated intracellular signilling by 3, 4-methylendioxymethamphetamine (MDMA). 2002
- Progettazione e sintesi di nuovi antagonisti del recettore A1 adenosinico. 2002
- Up-regulation of A2A adenosine receptors and modulation of apoptosis by pro-inflammatory cytokines in rat PC 12 cells 2002
- 2phenyl[1,2,3]triazolo [1,2-a][1,2,4] benzotriazin-1-one derivatives as a new class of adenosine receptor antagonists 2003
- A2B adenosine receptors in human astroglial cells:regulation of receptor expression and functioning by tumor necrosis factor alpha 2003
- Cyclic AMP inhibitory pathway in platelet of patients with panic disorders versus control 2003
- Tumor necrosis factor alpha regulates A2A adenosine receptors functioning and expression in human astroglial cells. 2003
- A2A adenosine receptors in platelets of healthy volunteers and patients affected by psycosis consuming caffeine 2004
- Cerebral focal ischemia "in vivo" and A2A adenosine receptors 2004
- Regulation of A2B adenosine receptor functioning by tumor necrosis factor alpha in human astroglial cells 2004
- Short-term regulation of A2B adenosine receptor functioning by tumor necrosis factor alpha in human astroglial cells 2004
- TNF-alpha-mediated regulation of A2B adenosine receptors in astroglial cells 2005
- Differenze di genere nei disturbi d’ansia: correlati neurobiologici. 2006
- Peripheral-type benzodiazepine receptor and steroid serum levels in civilian population with post-traumatic stress disorder 2006
- Stress e correlati neurobiologici. 2006
- A1 and P2Y1 purine receptors:localization and functional cross-talk in hippocampus 2007
- Adenosine/Dopamine receptor interaction: implication in antipsychotic therapy. 2007
- Functional interaction between A1 and P2Y1 purinergic receptors in the brain 2007
- Panic-agoraphobic spectrum comorbidity and mitochondrial translocator protein in post-traumatic stress disorder. 2007
- Attivazione delle MAP-Kinasi mediata dalla serotonina (5-HT) in pazienti affetti da Disturbo di Panico (DP), prima e dopo 6 mesi di trattamento con paroxetina, vs. controlli (C) 2008
- EXPRESSION AND ACTIVITY OF GPR17, A NEW NUCLEOTIDE-CYSTEINYL-LEUKOTRIENE RECEPTOR, IN NEURONAL PC12 CELL MODEL. 2008
- Livelli della proteina cAMP-Response Element Binding (CREB) e del recettore periferico mitocondriale per le benzodiazepine (PBR) in pazienti affetti da Disturbo Post-Traumatico da Stress (PTSD) vs. Controlli (C) 2008
- New pyrazolo 3,4-bpyridines antagonists of A1 adenosine receptors 2008
- Regolazione del recettore A2A dell'adenosina in piastrine di pazienti bipolari trattati con neurolettici tipici 2008
- Effect of typical and atypical antipsychotics on A2A adenosine receptor affinity and functional parameters in CHO transfected cells 2009
- Functional cross-talk between GPR17 and nerve growth factor in neuronal pheocromocytoma PC12 cell proliferation and differentiation. 2009
- Purinergic signaling and cell proliferation and differentiation in a neuronal pheocromocytoma PC12 cell model 2009
- Rational Design and Synthesis of Potent and Selective Adenosine Receptor Antagonists 2009
- Synthesis and biological evaluation on human glioblastoma cells of novel pyrazolo3,4-Dpyrimidine adenosine A3 receptor antagonists. 2009
- A new small molecule, D2 dopamine receptor agonist, as an allosteric modulator of A2A adenosine receptor signalling 2010
- A new small molecule, D2 dopamine receptor agonist, as an allosteric modulator of A2A adenosine receptor signalling 2010
- A new small molecule, D2 dopamine receptor agonist, as an allosteric modulator of A2A adenosine receptor signalling 2010
- EPOalfa and DarbEPO-mediated erythropoietin receptor desensitization/resensitization 2010
- Frontal Affinity Chromatography-Mass Spectrometry Useful for Characterization of New Ligands for GPR17 Receptor 2010
- GPR17 desensitization: cross-regulation between the purinergic and leukotriene binding site. 2010
- Studio clinico e neurobiologico in pazienti affetti da gioco d’azzardo patologico 2010
- The P2Y-like GPR17 receptor orchestrates the transition between immature and myelinating oligodendrocytes and is a new target for myelin repair 2010
- 3-Aryl-1,2,4triazino4,3-abenzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists. 2011
- Adenosine A2A receptors and psychiatric disorders 2011
- Agonist-induced desensitisation/resensitisation of human GPR17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands 2011
- D2 dopamine receptor agonists as allosteric modulators of A2A adenosine receptor signalling 2011
- GPR17 ligands: synthesis and characterization of new potent agonists. 2011
- Receptor insight: recent advances in the development of novel therapeutic agents 2011
- Role of the P2Y-like receptor GPR17 in neural precursor cells 2011
- Brevetti